RecruitingPhase 2NCT07570472

The Effect of CBD on Sleep Quality Following Late Evening Exercise


Sponsor

KU Leuven

Enrollment

20 participants

Start Date

Mar 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The trial is a double-blind, placebo-controlled crossover design. In a randomized order, 20 participants undergo one control and two experimental sessions separated by a 1-week wash out period. During the no exercise/rest session, participants' sleep is monitored via polysomnography following a rest day. During the training sessions participants' sleep is monitored following a high intensity interval training (HIIT) in the late evening (finishing 1h prior to bedtime). During these sessions participants receive 2x 200mg CBD or placebo in a randomized order.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cannabidiol or placebo and a behavioral approach called late evening exercise for people with sleep quality. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCannabidiol or placebo

participants receive 2 x 200mg CBD or placebo

BEHAVIORALlate evening exercise

Participants perform a late evening high-intensity interval training (HIIT) ending 1 hour prior to sleep


Locations(1)

Bakala Athletic Performance Facility

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07570472


Related Trials